Takeda Pharmaceutical (TKPHF) Dividends Paid - Common (2018 - 2026)

Takeda Pharmaceutical's Dividends Paid - Common history runs 9 years deep, the most recent figure standing at -$56.0 million for Q1 2026.

• In Q1 2026, Dividends Paid - Common rose 12.22% year-over-year to -$56.0 million; the TTM figure through Mar 2026 stood at -$2.1 billion (down 6.03% YoY), while the FY2026 annual figure was -$2.1 billion, down 4.34% from the prior year.
• Dividends Paid - Common was -$56.0 million for Q1 2026 at Takeda Pharmaceutical, up from -$968.4 million in the prior quarter.
• In the past five years, Dividends Paid - Common ranged from a high of $4.8 billion in Q1 2022 to a low of -$1.0 billion in Q2 2025.
• Historically, Dividends Paid - Common has averaged $279.2 million across 5 years, with a median of -$80.6 million in 2022.
• The sharpest annual moves came in 2023 and 2025: Dividends Paid - Common grew 22.14% in 2023, then tumbled 101.67% in 2025.
• A 5-year view of Dividends Paid - Common shows it stood at -$913.0 million in 2022, then declined by 2.44% to -$935.3 million in 2023, then declined by 2.29% to -$956.7 million in 2024, then slipped by 1.22% to -$968.4 million in 2025, then surged by 94.21% to -$56.0 million in 2026.
• The last three Dividends Paid - Common figures came in at -$56.0 million (Q1 2026), -$968.4 million (Q4 2025), and -$59.6 million (Q3 2025), per Business Quant data.